ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: pediatric

Expanding Lupus Awareness through Education

Collaborative Initiatives Department Staff  |  

With funding support from the CDC, in this ACR initiative, rheumatology fellows in training deliver lupus education sessions to medical personnel & rheumatologists connect with medical colleagues in underserved rural areas.

Insights into SLE & Lupus Nephritis From the 2025 Review Course

Jason Liebowitz, MD  |  

Review expert strategies & clinical pearls for managing SLE & lupus nephritis. Get therapeutic updates from the ACR’s 2025 Review Course.

Belimumab Promising for Children with Lupus Nephritis

  |  

In late July 2022, the U.S. Food & Drug Administration (FDA) approved belimumab (Benlysta) for the treatment of children with active lupus nephritis aged 5 to 17 years old receiving standard therapy.1 Despite recent advances in treatment options for patients with systemic lupus erythematosus (SLE), those with kidney involvement may develop endstage renal disease and…

Kidney Biopsy in Lupus Nephritis

  |  

As part of a session on lupus nephritis at ACR Convergence 2023, Simone Appenzeller, MD, PhD, shared perspectives on the importance of biopsy to inform the diagnosis, prognosis and treatment of the condition, with an emphasis on childhood disease. Prompt diagnosis and treatment of lupus nephritis is perhaps even more important for children than for…

The ACR Releases New Lupus Nephritis Guideline

  |  

At a session of ACR Convergence 2024, speakers shared key elements of the new guideline on the screening, treatment and overall management of lupus nephritis in children and adults.1 This guideline attempts to balance the risks of medication side effects with the important goal of preserving kidney function. This is the ACR’s first lupus guideline…

ACR Releases New Guideline for Management of SLE at ACR 2025

Mithu Maheswaranathan, MD  |  

Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.

JIA: The Transition to Adult Care

  |  

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.